EMA Withdrawn: Agenerase (amprenavir) — Glaxo Group Ltd.

View source ↗

Summary

Agenerase (amprenavir) has been withdrawn from the market in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Agenerase (amprenavir)

Snippet

Status: Withdrawn. Therapeutic area: HIV Infections. MAH: Glaxo Group Ltd.. Decision date: 29/04/2011